The World Health Organization (WHO) has approved Bavarian Nordic’s Jynneos mpox vaccine for adolescents aged 12 to 17 years, recognizing this age group as particularly vulnerable to outbreaks of the disease that has raised global health concerns. The post WHO approves Bavarian Nordic’s Mpox vaccine for adolescents appeared first on Nairametrics.
Related Articles
Don't miss out on breaking stories and in-depth articles.